Free Trial
NASDAQ:BKYI

BIO-key International Q3 2026 Earnings Date & Estimates

BIO-key International logo
$2.63 -0.32 (-10.85%)
Closing price 04:00 PM Eastern
Extended Trading
$2.60 -0.03 (-1.25%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BIO-key International is estimated to report Q3 2026 earnings on Friday, November 13, 2026. The conference call is scheduled for 10:00 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Conference Call
10:00 AM ET

What Analysts Expect from BIO-key International in Q3 2026

BIO-key International is expected to post earnings of -$0.35 per share on revenue of $2.40 million. In the same quarter a year earlier BIO-key International reported -$1.50 per share on revenue of $1.55 million. BIO-key International last reported on August 13, 2026, posting -$0.56 per share and beating the -$0.82 consensus estimate. BIO-key International has beaten the consensus EPS estimate in 3 of its last 7 quarters.

Consensus Estimates

Consensus EPS
-$0.35
Expected Revenue
$2.40 million
Prior-Year EPS
-$1.50
Prior-Year Revenue
$1.55 million
Expected Revenue Growth
+54.9%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.56 (Beat by +$0.26)
Last Quarter Revenue
$1.92 million
EPS Beat Rate
3 of last 7 quarters

BIO-key International Q3 2026 Earnings FAQ

BIO-key International (NASDAQ:BKYI) is estimated to report Q3 2026 earnings on Friday, November 13, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

BIO-key International's Q3 2026 earnings conference call is scheduled for Friday, November 13, 2026 at 10:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect BIO-key International to post earnings of -$0.35 per share for Q3 2026.

The consensus revenue estimate for BIO-key International is $2.40 million for Q3 2026.

BIO-key International Earnings Headlines

BIO-key International, Inc. Announces Management Changes
Trump’s issues shocking Executive Order on U.S. Dollar
Three days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.tc pixel
Why is BIO-key International stock surging Tuesday?
See More BIO-key International Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BIO-key International? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BIO-key International and other key companies, straight to your email.

About BIO-key International

BIO-key International (NASDAQ:BKYI), Inc. (NASDAQ: BKYI) develops biometric identity and access-management solutions. Its technology enables organizations to authenticate users through fingerprints and other biometric credentials, helping replace or supplement passwords while supporting secure access to applications, networks and devices.

The company’s offerings include biometric readers and software, as well as identity and access-management platforms such as PortalGuard and WEB-key. These products are designed to support multifactor authentication, single sign-on, password management and identity verification across on-premises and cloud-based environments.

BIO-key serves businesses, government agencies, educational institutions and other organizations that require secure user authentication. The company was founded in 1999 and is headquartered in New Jersey. Its solutions are marketed primarily in North America, with availability through technology partners and resellers in additional markets.

View BIO-key International Profile